CONTACT US
CONTACT US

February 18, 2019

Autologous mesenchymal stem cell application for cartilage defect in recurrent patellar dislocation: A case report

Introduction

Recurrent patellar dislocation is characterized by repeated episodes of knee cap displacement, often resulting in cartilage lesions and chronic symptoms. Traditional management approaches often yield limited success, necessitating innovative treatments such as mesenchymal stem cell (MSC) therapy.

Case Presentation

Patient History and Examination

A 21-year-old male presented with left knee discomfort following recurrent patellar dislocations over ten years. Physical examination revealed anterior knee pain exacerbated by activities like stair climbing and exercise. Diagnostic imaging confirmed significant cartilage defects, classified as Grade 3 according to ICRS standards.

Surgical Intervention

The patient underwent arthroscopic microfracture and autologous bone marrow-derived MSCs implantation following Fulkerson osteotomy. Surgical procedures included lateral retinaculum release and tibial tubercle realignment to stabilize the patella.

Treatment Outcome

Postoperative Recovery

Post-surgery, the patient achieved full range of motion and began weight-bearing exercises. Eighteen months later, MSC implantation facilitated significant cartilage growth, improving International Knee Documentation Committee (IKDC) and Visual Analog Scale (VAS) scores.

Long-term Assessment

Two years post-MSC treatment, the patient reported no knee complaints and maintained full range of motion. MRI confirmed substantial cartilage regeneration in previously damaged areas.

Discussion

Challenges in Management

Recurrent patellar dislocations pose challenges due to high recurrence rates and associated cartilage damage. Treatment strategies like Fulkerson osteotomy combined with MSC therapy offer promising outcomes for severe cases.

Role of MSC Therapy

MSCs demonstrate potential in cartilage regeneration due to their chondrogenic differentiation capabilities and anti-inflammatory properties. This case highlights the efficacy of MSC therapy in managing extensive cartilage defects.

Conclusion

Combining Fulkerson osteotomy with MSC implantation represents a viable treatment option for chronic patellar instability and associated cartilage lesions. The integration of microfracture and MSC therapy supports significant cartilage regeneration and functional recovery.

Related Posts

Global Stem Cells Group and ReGen Forge Partnership with Churchill Aesthetic Center in Brussels, Belgium
Inauguration Ceremony Marks Landmark Occasion for Regenerative Medicine in theRegion April 22,...
Read More
International Society for Stem Cell Application Presents International Certification in Cellular Therapies Training in Seoul, Korea
The International Society for Stem Cell Application (ISSCA) proudly announces the upcoming...
Read More
International Society for Stem Cell Application (ISSCA) Returns to Peru with WorldConference on Regenerative Medicine and Cellular Therapies
Miami, Florida – The International Society for Stem Cell Application (ISSCA), adistinguished...
Read More
Privacy Policy           Terms of Service         2025.All rights reserved.

Datran Center. 9100 S. Dadeland Boulevard, Suite 1500. Miami Fl. 33156. United States
Open chat
Have questions?
Get in contact with us...
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram